Drug Pipeline

tisotumab vedotin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT06459180
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of…		 overall status: "Recruiting" → "Active Not Recruiting"
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06952660 Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical… Cervical Cancer Recruiting
Phase 3
NCT06459180 A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… Cervical Cancer Active, Not Recruiting
Phase 2
NCT03485209 Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors Colorectal Neoplasms Active, Not Recruiting
Sponsors Running tisotumab vedotin Trials
Seagen, a wholly owned subsidiary of Pfizer (1) Merck Sharp & Dohme LLC (1) Pfizer (1)
Disease Areas
Cervical Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Colorectal Cancer (1) Pancreatic Cancer (1)
Get alerts when tisotumab vedotin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free